130 related articles for article (PubMed ID: 37931687)
21. Altered peritumoral microRNA expression predicts head and neck cancer patients with a high risk of recurrence.
Ganci F; Sacconi A; Manciocco V; Covello R; Benevolo M; Rollo F; Strano S; Valsoni S; Bicciato S; Spriano G; Muti P; Fontemaggi G; Blandino G
Mod Pathol; 2017 Oct; 30(10):1387-1401. PubMed ID: 28731048
[TBL] [Abstract][Full Text] [Related]
22. Surgical management of recurrent cutaneous squamous cell carcinoma of the head and neck after definitive surgery and radiotherapy.
Toppi J; Tham YS; Webb A; Henderson MA; Rischin D; Magarey MJR
ANZ J Surg; 2020 Jul; 90(7-8):1391-1395. PubMed ID: 32627359
[TBL] [Abstract][Full Text] [Related]
23. Biological predictors of radiosensitivity in head and neck squamous cell carcinoma.
Fiedler M; Weber F; Hautmann MG; Haubner F; Reichert TE; Klingelhöffer C; Schreml S; Meier JK; Hartmann A; Ettl T
Clin Oral Investig; 2018 Jan; 22(1):189-200. PubMed ID: 28315964
[TBL] [Abstract][Full Text] [Related]
24. Clinical analysis of second primary gingival squamous cell carcinoma after radiotherapy.
Fu X; Chen S; Chen W; Yang Z; Song M; Li H; Zhang H; Yao F; Su X; Liu T; Yang AK
Oral Oncol; 2018 Sep; 84():20-24. PubMed ID: 30115471
[TBL] [Abstract][Full Text] [Related]
25. A novel panel of biomarkers predicts radioresistance in patients with squamous cell carcinoma of the head and neck.
Akervall J; Nandalur S; Zhang J; Qian CN; Goldstein N; Gyllerup P; Gardinger Y; Alm J; Lorenc K; Nilsson K; Resau J; Wilson G; Teh B
Eur J Cancer; 2014 Feb; 50(3):570-81. PubMed ID: 24332450
[TBL] [Abstract][Full Text] [Related]
26. Integrative genomic and functional analysis of human oral squamous cell carcinoma cell lines reveals synergistic effects of FAT1 and CASP8 inactivation.
Hayes TF; Benaich N; Goldie SJ; Sipilä K; Ames-Draycott A; Cai W; Yin G; Watt FM
Cancer Lett; 2016 Dec; 383(1):106-114. PubMed ID: 27693639
[TBL] [Abstract][Full Text] [Related]
27. Effect of radiotherapy on head and neck cancer tissues in patients receiving radiotherapy: a bioinformatics analysis-based study.
Guan Z; Liu J; Zheng L
Sci Rep; 2024 Mar; 14(1):6304. PubMed ID: 38491080
[TBL] [Abstract][Full Text] [Related]
28. p53 and Ki-67 as markers of radioresistance in head and neck carcinoma.
Couture C; Raybaud-Diogène H; Têtu B; Bairati I; Murry D; Allard J; Fortin A
Cancer; 2002 Feb; 94(3):713-22. PubMed ID: 11857304
[TBL] [Abstract][Full Text] [Related]
29. Changes of mutant-type p53 expression in squamous cell carcinoma of the head and neck during radiation therapy and its clinical significance: comparison of an immunohistochemical method and PCR-SSCP assay.
Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
Oncol Rep; 1998; 5(5):1053-9. PubMed ID: 9683807
[TBL] [Abstract][Full Text] [Related]
30. Comparisons of the clinical outcomes of different postoperative radiation strategies for treatment of head and neck squamous cell carcinoma.
Makita C; Kodaira T; Daimon T; Tachibana H; Tomita N; Koide Y; Koide Y; Fukuda Y; Nishikawa D; Suzuki H; Hanai N; Hasegawa Y
Jpn J Clin Oncol; 2017 Dec; 47(12):1141-1150. PubMed ID: 29036621
[TBL] [Abstract][Full Text] [Related]
31. Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08.
Fu KK; Hammond E; Pajak TF; Clery M; Doggett RL; Byhardt RW; McDonald S; Cooper JS
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):661-71. PubMed ID: 7913703
[TBL] [Abstract][Full Text] [Related]
32. Analysis of specific survival and local control through a recursive partitioning analysis in patients with head and neck carcinoma.
León X; Rodriguez C; Rovira C; García J; López M; Quer M
Acta Otorrinolaringol Esp (Engl Ed); 2020; 71(3):131-139. PubMed ID: 31060733
[TBL] [Abstract][Full Text] [Related]
33. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
[TBL] [Abstract][Full Text] [Related]
34. Development of a prediction model for radiotherapy response among patients with head and neck squamous cell carcinoma based on the tumor immune microenvironment and hypoxia signature.
Zhu GL; Yang KB; Xu C; Feng RJ; Li WF; Ma J
Cancer Med; 2022 Dec; 11(23):4673-4687. PubMed ID: 35505641
[TBL] [Abstract][Full Text] [Related]
35. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P
BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688
[TBL] [Abstract][Full Text] [Related]
36. The prognostic value of pretreatment platelet count in patients with head and neck squamous cell carcinoma.
Pardo L; Valero C; López M; García J; Camacho M; Quer M; León X
Auris Nasus Larynx; 2017 Jun; 44(3):313-318. PubMed ID: 27401121
[TBL] [Abstract][Full Text] [Related]
37. [Postoperative radiotherapy with cetuximab for head and neck squamous cell carcinoma patients at high risk of recurrence not eligible for cisplatin: A single-center experience and literature review].
Marques O; Brenet E; Gaultier V; Marchand-Crety C
Cancer Radiother; 2023 Feb; 27(1):17-22. PubMed ID: 35853823
[TBL] [Abstract][Full Text] [Related]
38. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate.
Strojan P; Corry J; Eisbruch A; Vermorken JB; Mendenhall WM; Lee AW; Haigentz M; Beitler JJ; de Bree R; Takes RP; Paleri V; Kelly CG; Genden EM; Bradford CR; Harrison LB; Rinaldo A; Ferlito A
Head Neck; 2015 Jan; 37(1):134-50. PubMed ID: 24481720
[TBL] [Abstract][Full Text] [Related]
39.
van den Bosch S; Doornaert PAH; Dijkema T; Zwijnenburg EM; Verhoef LCG; Hoeben BAW; Kasperts N; Smid EJ; Terhaard CHJ; Kaanders JHAM
Radiother Oncol; 2020 Jan; 142():107-114. PubMed ID: 31439447
[TBL] [Abstract][Full Text] [Related]
40. Neck Imaging Reporting and Data System Category 3 on Surveillance Computed Tomography: Incidence, Biopsy Rate, and Predictive Performance in Head and Neck Squamous Cell Carcinoma.
Johansson ED; Hughes RT; Meegalla NT; Porosnicu M; Patwa HS; Lack CM; Bunch PM
Laryngoscope; 2022 Sep; 132(9):1792-1797. PubMed ID: 35043989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]